Höpfner, Michael, Sutter, Andreas P, Huether, Alexander, Ahnert-Hilger, Gudrun, Scherübl, Hans
Abstract Background Therapeutic options to effectively inhibit growth and spread of neuroendocrine gastrointestinal tumors are still limited. As both meta-iodobenzylguanidine (MIBG) and interferon-γ...
Höpfner, Michael, Schuppan, Detlef, Scherübl, Hans
Growth factors and their corresponding receptors are commonly overexpressed and/or dysregulated in many cancers including hepatocellular cancer (HCC). Clinical trials indicate that growth factor...
Höpfner, Michael, Schuppan, Detlef, Scherübl, Hans
The limited efficacy of conventional cytotoxic treatment regimes for advanced gastrointestinal neuroendocrine cancers emphasizes the need for novel and more effective medical treatment options....
Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives
Höpfner, Michael, Schuppan, Detlef, Scherübl, Hans
The limited efficacy of cytotoxic therapy for advanced biliary tract and gallbladder cancers emphasizes the need for novel and more effective medical treatment options. A better understanding of the...